The SUSTAIN-6 Trial (Once-Weekly Semaglutide) The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) consisted of 3297 people living with T2DM, 83% with established cardiovascular disease, receiving once-weekly semaglutide (0.5 and 1.0 mg) or placebo
But the full picture is more nuanced than a simple dont take it. This guide covers everything you need to know: what the research actually shows, when to stop if youre planning pregnancy, what to do if youve already been exposed, and how these medications might actually be affecting your fertility in ways you didnt expect
By supporting the mitochondria (the powerhouses of your cells), NAD+ optimizes your bodys ability to convert food into energy and supports liver enzymes essential for efficient detoxification and waste removal
Get 10% off your first order when you sign up
Winners will pair low price with fast regulatory clearance, device equivalence, and contracted access